Mold-Tek Packaging reports strong half-year growth in key segments

Mold-Tek Packaging Limited announced a 16% increase in total revenue for H1 FY26, reaching INR 450.32cr, with sales volume growing by 11% to 21,936 MT. EBIDTA surged by 23% to INR 86.88cr, and PAT rose by 24% to INR 37.88cr, underscoring strong financial health and operational efficiency. This performance was bolstered by a 35% growth in pharma over Q1 and significant gains in Q Pack sales and paint sales, alongside a 19.55% increase in thin wall food packaging.

The company's strategic focus on the pharma segment is evident, with sales reaching INR 10.81 Cr in Q2 FY25, a 35% volume growth over Q1. This growth is attributed to its leadership in IML, DMF facility, and high hygiene standards, which have helped Mold-Tek dominate the EV tubes and stoppers market for nutraceuticals. Further capacity expansions are planned by Q3 2026.

Operational improvements include the full establishment of a new off-set machine in Q2, handling a record 3350 SKUs, and streamlined RCPP processes. The outlook for food & FMCG is positive, with a new Panipat facility expected to boost contributions from Q3 and new product shapes from Q4, reinforcing Mold-Tek’s commitment to innovation and market expansion.